Hyperglycemia and reduced adiposity of streptozotocin-induced diabetic mice are not alleviated by oral benzylamine supplementation

BACKGROUND: Benzylamine (Bza) oral administration delays the onset of hyperglycemia in insulin-resistant db(-/- )mice; a genetic model of obesity and type 2 diabetes. AIM: To extend the antihyperglycemic properties of oral benzylamine to a model of insulin-deficient type 1 diabetes. METHODS: Male Sw...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpéné, Christian, Stiliyanov Atanasov, Kristiyan, Les, Francisco, Mercader Barcelo, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521444/
https://www.ncbi.nlm.nih.gov/pubmed/36188146
http://dx.doi.org/10.4239/wjd.v13.i9.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521444/
https://www.ncbi.nlm.nih.gov/pubmed/36188146
http://dx.doi.org/10.4239/wjd.v13.i9.752

Ejemplares similares